Pliant Therapeutics Stock Forecast

Stock Price Forecast

The 7 analysts that cover Pliant Therapeutics stock have a consensus rating of "Hold" and an average price target of $3.93, which forecasts a 171.03% increase in the stock price over the next year. The lowest target is $1.50 and the highest is $10.

Price Target: $3.93 (+171.03%)

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$1.50	$3.93	$3.00	$10
Change	+3.45%	+171.03%	+106.90%	+589.66%

Analyst Ratings

The average analyst rating for Pliant Therapeutics stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Mar '25	Apr '25	May '25	Jun '25	Jul '25	Aug '25
Strong Buy	0	0	0	0	0	0
Buy	1	1	1	1	1	1
Hold	9	9	9	9	9	9
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	10	10	10	10	10	10

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Yasmeen Rahimi Piper Sandler	Piper Sandler	Buy Maintains $17 → $4	Buy	Maintains	$17 → $4	+175.86%	Aug 8, 2025
Ed Arce HC Wainwright & Co.	HC Wainwright & Co.	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Mar 18, 2025
Ed Arce HC Wainwright & Co.	HC Wainwright & Co.	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Mar 4, 2025
David Lebowitz Citigroup	Citigroup	Hold Maintains $4 → $1.5	Hold	Maintains	$4 → $1.5	+3.45%	Mar 4, 2025
Brian Abrahams RBC Capital	RBC Capital	Hold Maintains $4 → $3	Hold	Maintains	$4 → $3	+106.90%	Mar 4, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

2.27M

Revenue Next Year

1.70M

from 2.27M

-25.01%

from 2.27M

EPS This Year

-2.64

from -3.47

EPS Next Year

-1.89

from -2.64

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	41.82M	7.57M	9.69M	1.58M	-	2.27M	1.70M	29.91M
Revenue Growth	-26.70%	-81.89%	27.91%	-83.69%	-	-	-25.01%	1,659.53%
EPS	-1.95	-2.71	-2.94	-2.75	-3.47	-2.64	-1.89	-1.31
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	15	15	12

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	21.0M	15.8M	199.8M
Avg	2.3M	1.7M	29.9M
Low	n/a	n/a	n/a

Revenue Growth

Revenue Growth	2025	2026	2027
High	-	594.8%	11,652.4%
Avg	-	-25.0%	1,659.5%
Low	-	-	-

EPS Forecast

EPS	2025	2026	2027
High	-2.37	-1.08	-0.17
Avg	-2.64	-1.89	-1.31
Low	-3.07	-2.70	-2.87

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.